Peptide Research News - Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose ... - MarketWatch (press release)

Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose ... - MarketWatch (press release)

Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose ... MarketWatch (press release) BOONTON, NJ, May 22, 2012 /PRNewswire via COMTEX/ -- Unigene Laboratories, Inc. (OBB:UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics today reported positive data from recently completed preclinical ... and more »

Click Here to read the entire article...